R. Haddad, P. Braschayko, S. Sonis, M. Posner, L. Wirth, R. Tishler
{"title":"O28。在新诊断的局部晚期头颈癌患者中,每周使用卡铂/紫杉醇/联合增强放疗加或不加每日皮下氨磷汀的随机II期研究","authors":"R. Haddad, P. Braschayko, S. Sonis, M. Posner, L. Wirth, R. Tishler","doi":"10.1016/J.OOS.2009.06.113","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100991,"journal":{"name":"Oral Oncology Supplement","volume":"31 1","pages":"65"},"PeriodicalIF":0.0000,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"O28. Randomized phase II study of concomitant chemoradiation using weekly carboplatin/paclitaxel/concomitant boost radiation with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced head and neck cancer\",\"authors\":\"R. Haddad, P. Braschayko, S. Sonis, M. Posner, L. Wirth, R. Tishler\",\"doi\":\"10.1016/J.OOS.2009.06.113\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100991,\"journal\":{\"name\":\"Oral Oncology Supplement\",\"volume\":\"31 1\",\"pages\":\"65\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Oncology Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.OOS.2009.06.113\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Oncology Supplement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.OOS.2009.06.113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
O28. Randomized phase II study of concomitant chemoradiation using weekly carboplatin/paclitaxel/concomitant boost radiation with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced head and neck cancer